FR941128-2-00098 FR941128-2-00050 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Termination of Temporary Deferment of Activities Relating to Biologics Submissions and Notice of New Mailing Address; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 23, 1994 (59 FR 48895). The document announced the new address for submissions and identified the exact period which action on pending submissions was temporarily deferred. The agency also announced the installation of automated systems to make information available to the public and to help callers identify the new telephone numbers of Center for Biologics and Evaluation staff involved in review activities. The document was published with a typographical error. This document corrects that error. FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy (HF&hyph;27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2994. In FR Doc. 94&hyph;23617, appearing on page 48895, in the Federal Register of September 23, 1994, the following correction is made: On page 48895, in the second column, in the fourth line from the bottom, the phone number ``549&hyph;5656'' is corrected to read ``594&hyph;5656''. Dated: November 17, 1994. William K. Hubbard, Interim Deputy Commissioner for Policy. [FR Doc. 94&hyph;29115 Filed 11&hyph;25&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
